Mendez, Conrado A.

HRN: 05-00-00  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2022
CEFTRIAXONE 1G (VIAL)
05/04/2022
05/11/2022
IV
2 G
OD
PTB Cat. II
Waiting Final Action 
05/11/2022
CEFIXIME 200MG (CAP)
05/11/2022
05/16/2022
PO
200mg
BID
CAP MR
Waiting Final Action 
05/11/2022
CO-AMOXICLAV 625MG (TAB)
05/11/2022
05/16/2022
PO
625mg
BID
CAP MR
Waiting Final Action 
05/27/2022
CEFTAZIDIME 1GM (VIAL)
05/27/2022
06/02/2022
IVT
1g
Q8
CAP MR; PTB
Waiting Final Action 
06/04/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/04/2022
06/10/2022
IV
4.5gm
Q6h
CAP HR; PTB
Waiting Final Action 
06/10/2022
LEVOFLOXACIN 500MG (TAB)
06/10/2022
06/16/2022
PO
500mgtab; 1 1/2 Tab
OD
Massive Pleural Effusion Right - Sepsis Sec To #1
Waiting Final Action 
06/11/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/11/2022
06/12/2022
IV
4.5gm
Q6
Massive Pleural Effusion Right - Sepsis Sec To #1
Waiting Final Action 
06/13/2022
CEFTAZIDIME 1GM (VIAL)
06/13/2022
06/19/2022
IV
1gm
Q8
Massive Pleural Effusion Right - Sepsis Sec To #1
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: